259 related articles for article (PubMed ID: 32920121)
21. Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study.
Bhattacharya S; Banerjee A; Ray S
Int J Biol Macromol; 2021 Mar; 172():74-81. PubMed ID: 33385461
[TBL] [Abstract][Full Text] [Related]
22. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
23. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2.
Chakraborty C; Sharma AR; Bhattacharya M; Sharma G; Lee SS
Arch Med Res; 2021 May; 52(4):362-370. PubMed ID: 33546870
[TBL] [Abstract][Full Text] [Related]
24. In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19.
Can H; Köseoğlu AE; Erkunt Alak S; Güvendi M; Döşkaya M; Karakavuk M; Gürüz AY; Ün C
Sci Rep; 2020 Dec; 10(1):22387. PubMed ID: 33372181
[TBL] [Abstract][Full Text] [Related]
25. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
Chauhan V; Rungta T; Rawat M; Goyal K; Gupta Y; Singh MP
J Cell Physiol; 2021 Feb; 236(2):1131-1147. PubMed ID: 32643158
[TBL] [Abstract][Full Text] [Related]
26. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
27. Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets.
Mukherjee S; Tworowski D; Detroja R; Mukherjee SB; Frenkel-Morgenstern M
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32526960
[TBL] [Abstract][Full Text] [Related]
28. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
Devi YD; Goswami HB; Konwar S; Doley C; Dolley A; Devi A; Chongtham C; Dowerah D; Biswa V; Jamir L; Kumar A; Satapathy SS; Ray SK; Deka RC; Doley R; Mandal M; Das S; Singh CS; Borah PP; Nath P; Namsa ND
PLoS One; 2021; 16(11):e0258645. PubMed ID: 34780495
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.
Grifoni A; Sidney J; Vita R; Peters B; Crotty S; Weiskopf D; Sette A
Cell Host Microbe; 2021 Jul; 29(7):1076-1092. PubMed ID: 34237248
[TBL] [Abstract][Full Text] [Related]
30. Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
Bose T; Pant N; Pinna NK; Bhar S; Dutta A; Mande SS
Virus Res; 2021 Nov; 305():198579. PubMed ID: 34560183
[TBL] [Abstract][Full Text] [Related]
31. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.
Yu M; Zhu Y; Li Y; Chen Z; Li Z; Wang J; Li Z; Zhang F; Ding J
Front Immunol; 2022; 13():884433. PubMed ID: 35603198
[TBL] [Abstract][Full Text] [Related]
32. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
Poluektov Y; George M; Daftarian P; Delcommenne MC
Vaccine; 2021 Apr; 39(15):2110-2116. PubMed ID: 33744048
[TBL] [Abstract][Full Text] [Related]
33. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19.
Sadat SM; Aghadadeghi MR; Yousefi M; Khodaei A; Sadat Larijani M; Bahramali G
Mol Biotechnol; 2021 May; 63(5):389-409. PubMed ID: 33625681
[TBL] [Abstract][Full Text] [Related]
36. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
Balz K; Kaushik A; Chen M; Cemic F; Heger V; Renz H; Nadeau K; Skevaki C
Sci Rep; 2021 Feb; 11(1):4792. PubMed ID: 33637823
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
Front Immunol; 2020; 11():2008. PubMed ID: 33013857
[TBL] [Abstract][Full Text] [Related]
38. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
[TBL] [Abstract][Full Text] [Related]
39. Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
Das BK; Chakraborty D
J Phys Chem Lett; 2020 Nov; 11(22):9920-9930. PubMed ID: 33174418
[TBL] [Abstract][Full Text] [Related]
40. Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants.
Meyer S; Blaas I; Bollineni RC; Delic-Sarac M; Tran TT; Knetter C; Dai KZ; Madssen TS; Vaage JT; Gustavsen A; Yang W; Nissen-Meyer LSH; Douvlataniotis K; Laos M; Nielsen MM; Thiede B; Søraas A; Lund-Johansen F; Rustad EH; Olweus J
Cell Rep; 2023 Jan; 42(1):111995. PubMed ID: 36656713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
